There’s a medical breakthrough for the deaf.
Scientists at United Kingdom’s Sheffield University have created stem cells from embryos to replace damaged cells in the inner ear — reversing hearing loss.
The embryonic stem cells could be converted into workable hearing cells for people born with inherited hearing problems and who’ve suffered damage to their ear cells during their lifetime, according to the scientists.
The breakthrough stem-cell discovery is “incredibly promising” and “opens up exciting possibilities,” Dr. Ralph Holme, a biomedical researcher, told the British Broadcasting Corporation.
But the stem-cell research could be halted by critics who argue that the controversial
Hundreds of thousands of people suffer from hereditary diabetes, a condition that destroys cells in the pancreas and leaves the body unable to regulate blood sugar levels.
Sufferers are forced to inject themselves with insulin everyday and adopt special diets to cope with the irreversible condition.
But now scientists claim a cure could be developed after cells in the liver were converted to insulin producers in research on mice.
They believe the process, described in the journal Developmental Cell, could one day lead to a permanent one-off cure for the disease.
Piero Anversa, Italian scientist and director of regenerative medicine at the Brigham and Women’s Hospital of Harvard University in Boston is ready to perform the first biological by-pass in history. This evening in Milan during a meeting called ‘Futuro della Sanita’ (The Future of Health), Anversa explained that he has identified human coronary stem cells able to develop into coronary artery tissue.
He said, “My dream is for someone to have a heart attack, come to the hospital, and return home healthy.” For that to occur, it will be necessary to reproduce muscle and the large coronary vessels.
An estimated 400.000 Americans suffer from multiple sclerosis, but the findings of a new clinical trial shows promise in the fight to reverse symptoms of MS.
Researchers at Northwestern University conducted a trial using patients’ own stem cells to treat symptoms of multiple sclerosis, reports Early Show correspondent Debbye Turner Bell, and although the study group was small — only 21 patients participated in it — the findings are a huge breakthrough in the fight against MS.
Edwin McClure is strong and healthy now, but just four years ago, his life was very different.
“I would get fatigued. I couldn’t deal with
StemCells, Inc. announced today that the California Institute of Regenerative Medicine (CIRM) has approved the Company’s application for a “Disease Team Therapy Development Planning Award.”
The grant, totaling approximately $100,000, will help fund the Company’s plans to develop its proprietary human neural stem cell product, HuCNS-SC(R) cells, in Alzheimer’s disease by enabling the Company and its collaborators at the University of California, Irvine, to prepare and submit an application for a “Disease Team Therapy Development Research Award.”
The CIRM has indicated that each Research Award will be up to $20 million, payable over four years, to fund preclinical and IND-enabling activities